Username Password
S&P 500: 2,063.50
Change: +0.72%

EXELIXIS INC. (EXEL)

Overview
Price 1.76
Price Change Today +$0.06 (+3.53%)
P&P rating Rating: 3
Open Price $1.78
Previous Close $1.70
Daily Range $1.69 - $1.78
52-Week Range $1.35 - $8.41
Volume 1
chart
Top Buy Analysis
BUY: EXEL Rating: 3
Company: EXELIXIS INC.
Points: -122.91
Start Price: $5.57
Start Date: 06/11/2008 6:52 PM
GreedsGood
GreedsGood
P&P Score: 64.11
Recs:
Undervalued

Comments: 0 | Comment

Top Sell Analysis
SELL: EXEL Rating: 3
Company: EXELIXIS INC.
Points: 143.47
Start Price: $9.35
Start Date: 06/19/2011 9:24 AM
Hqdepot
Hqdepot
P&P Score: 43.41
Recs:
I bought at 2.99 and took a 100+ gain at 6.45. Then I watched it ratchet up to 12. Makes you want to put on a blindfold and slide quarters into a slot machine. Anyway. It looks tenuous here and the news concerning side effects of their big Phase 3 drug is not promising. I see some downside to the 6.5 area here.

Comments: 0 | Comment

Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

28 Buy
1 Sell
 
Free Options Trader Guide
Blog Posts
User User Score Date Title Comments Last Comment
zantriocom
0.00 03/10/10 Zantrio.com Free Daily Stock Picks 3-10-2010 0
zantriocom
0.00 11/09/09 Zantrio.com Free Daily Stock Picks 11-9-09 0
Zacks_Analysts
0.00 01/18/13 Pipeline Advances at Exelixis - Analyst Blog 0
Zacks_Analysts
0.00 01/18/13 Pipeline Advances at Exelixis - Analyst Blog 0
Zacks_Analysts
0.00 12/20/10 Sanofi Expands Oncology Pipeline - Analyst Blog 0
Zacks_Analysts
0.00 07/26/10 Sanofi Launches Cancer Treatment - Analyst Blog 0
Zacks_Analysts
0.00 06/30/10 Sanofi to Acquire TargaGen - Analyst Blog 0
Zacks_Analysts
0.00 06/22/10 BMY Terminates EXEL Partnership - Analyst Blog 0
Zacks_Analysts
0.00 06/18/10 FDA Approves Sanofi Drug - Analyst Blog 0
Zacks_Analysts
0.00 06/07/10 Sanofi Expands Oncology Pipeline - Analyst Blog 0
Pages: [ 1 ]  2  >>
Commentary
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $4.77
Points: -88.12
Created: 05/23/2013
Phase 3 trials nearing completion. Great preliminary results against various cancers.

Comments: 0 | Comment

Recs:
 
SELL: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $9.35
Points: +143.47
Created: 06/19/2011
I bought at 2.99 and took a 100+ gain at 6.45. Then I watched it ratchet up to 12. Makes you want to put on a blindfold and slide quarters into a slot machine. Anyway. It looks tenuous here and the news concerning side effects of their big Phase 3 drug is not promising. I see some downside to the 6.5 area here.

Comments: 0 | Comment

Recs:
 
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $12.35
Points: -138.91
Created: 04/26/2011
Ready to break out of weekly and monthly charts plus close to breaking out of short term consolidation

Comments: 1 | Comment

Recs:
 
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $7.21
Points: -141.79
Created: 12/14/2010
promising medicin

Comments: 0 | Comment

Recs:
 
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $5.57
Points: -122.91
Created: 06/11/2008
Undervalued

Comments: 0 | Comment

Recs:
 
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $6.50
Points: -122.76
Created: 06/04/2008
Phase 2 and 3's are coming!!!! 500% gain in 5 years if not more.

Comments: 0 | Comment

Recs:
 
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $5.57
Points: -138.96
Created: 10/19/2011
buy

Comments: 0 | Comment

Recs:
 
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $4.33
Points: -135.76
Created: 10/12/2010

Comments: 0 | Comment

Recs:
 
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $3.58
Points: -151.56
Created: 07/06/2010

Comments: 0 | Comment

Recs:
 
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $7.20
Points: -116.12
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
Pages: [ 1 ]  2   3  >>
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
BriansLongshots 1.36 BUY Three Plus Years 05/23/2013 $4.77 $1.76
(+3.53%)
-63.10% +25.02% -88.12 view
rtezanos 28.37 BUY Week or Less 10/19/2011 $5.57 $1.76
(+3.53%)
-68.40% +70.55% -138.96 view
Hqdepot 43.41 SELL Six Months to a Year 06/19/2011 $9.35 $1.76
(+3.53%)
-81.18% +62.29% +143.47 view
wallstreeter 28.15 BUY Six Months to a Year 04/26/2011 $12.35 $1.76
(+3.53%)
-85.75% +53.16% -138.91 view
cmmtgnmn 42.77 BUY Six Months to a Year 12/14/2010 $7.21 $1.76
(+3.53%)
-75.59% +66.20% -141.79 view
EyePhone 64.30 BUY One to Three Months 10/12/2010 $4.33 $1.76
(+3.53%)
-59.35% +76.40% -135.76
HardTimes 63.23 BUY One to Three Months 07/06/2010 $3.58 $1.76
(+3.53%)
-50.84% +100.72% -151.56
GreedsGood 64.11 BUY One to Three Years 06/11/2008 $5.57 $1.76
(+3.53%)
-68.40% +54.51% -122.91 view
POTASHKing 11.58 BUY Three Plus Years 06/04/2008 $6.50 $1.76
(+3.53%)
-72.92% +49.83% -122.76 view
Dave Brushart 81.70 BUY Six Months to a Year 01/01/2008 $7.20 $1.76
(+3.53%)
-75.56% +40.57% -116.12
Pages: [ 1 ]  2   3  >>
Sponsored Links